| Factor Information | |
|---|---|
| Data ID | 3173 |
| Factor | maintenance dose of sotalol |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The purpose of this study was to assess the efficacy and safety of sotalol for refractory tachyarrhythmias in patients with CHD. |
| p Value | 0.0026 |
| Conclusion | The maintenance dose was lower in patients with complete control than in patients with partial control or failure. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 659 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
| Reference | |
|---|---|
| PMID | 18931451 |
| Year | 2008 |
| Title | Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | patients' data | |
| Region | Suita, Japan | |
| Method | Fisher's exact test | |
| Race | Japanese | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | complete control of tachyarrhythmias group (Treatment) | partial control of tachyarrhythmias group (Control) |
| Number | 23 | 14 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 67±20 mg/m2/day | 101±32 mg/m2/day |
